Breaking News

Friday
Show Full Stories

X

To view all stories in expanded form, please subscribe.
Send Info
On The Fly
Sell these stocks now, proven algorithm says » 11:09
07/01/22
07/01
11:09
07/01/22
11:09
RIVN

Rivian Automotive

$25.76 /

+0.03 (+0.12%)

, FTCH

Farfetch

$7.36 /

+0.18 (+2.51%)

, SEDG

SolarEdge

$276.44 /

+3.57 (+1.31%)

, CRON

Cronos Group

$2.82 /

+0.01 (+0.36%)

, SQ

Block

$63.57 /

+2.08 (+3.38%)

, WRBY

Warby Parker

$11.19 /

-0.05 (-0.44%)

, SNAP

Snap

$12.89 /

-0.23 (-1.75%)

, NEO

NeoGenomics

$8.40 /

+0.25 (+3.07%)

, MSTR

MicroStrategy

$165.00 /

+1.67 (+1.02%)

, LSPD

Lightspeed

$22.64 /

+0.36 (+1.62%)

, BILI

Bilibili

$26.11 /

+0.52 (+2.03%)

, GDS

GDS Holdings

$34.16 /

+0.86 (+2.58%)

, NUTX

Nutex Health

$3.31 /

+0.09 (+2.80%)

, RXRX

Recursion Pharmaceuticals

$8.65 /

+0.52 (+6.40%)

Each week, The Fly will…

ShowHide Related Items >><<
WRBY Warby Parker
$11.19 /

-0.05 (-0.44%)

SQ Block
$63.57 /

+2.08 (+3.38%)

SNAP Snap
$12.89 /

-0.23 (-1.75%)

SEDG SolarEdge
$276.44 /

+3.57 (+1.31%)

RXRX Recursion Pharmaceuticals
$8.65 /

+0.52 (+6.40%)

RIVN Rivian Automotive
$25.76 /

+0.03 (+0.12%)

NUTX Nutex Health
$3.31 /

+0.09 (+2.80%)

NEO NeoGenomics
$8.40 /

+0.25 (+3.07%)

MSTR MicroStrategy
$165.00 /

+1.67 (+1.02%)

LSPD Lightspeed
$22.64 /

+0.36 (+1.62%)

GDS GDS Holdings
$34.16 /

+0.86 (+2.58%)

FTCH Farfetch
$7.36 /

+0.18 (+2.51%)

CRON Cronos Group
$2.82 /

+0.01 (+0.36%)

BILI Bilibili
$26.11 /

+0.52 (+2.03%)

RIVN Rivian Automotive
$25.76 /

+0.03 (+0.12%)

06/30/22 RBC Capital
RBC confident in Rivian Automotive achieving Q2 delivery estimates
06/27/22 Mizuho
Rivian Automotive price target lowered to $70 from $80 at Mizuho
06/15/22 Mizuho
Mizuho likes three electric vehicle stocks into second half rebound
06/06/22 Deutsche Bank
Tesla workforce reduction 'direct warning' to industry, says Deutsche Bank
FTCH Farfetch
$7.36 /

+0.18 (+2.51%)

06/29/22 JPMorgan
Farfetch price target lowered to $16 from $20 at JPMorgan
06/28/22 UBS
UBS downgrades 'profitless-tech company' Farfetch to Neutral
06/28/22 UBS
Farfetch downgraded to Neutral from Buy at UBS
06/06/22 Cowen
Farfetch price target lowered to $11 from $30 at Cowen
SEDG SolarEdge
$276.44 /

+3.57 (+1.31%)

06/29/22 Roth Capital
Roth sees CBP requiring quartzite docs as 'major problem' for solar industry
06/29/22 Wells Fargo
Generac initiated with an Overweight at Wells Fargo
06/02/22 Oppenheimer
Oppenheimer upgrades SolarEdge to Outperform with $334 price target
06/02/22 Oppenheimer
Oppenheimer upgrades Wolfspeed to Outperform with $105 price target
CRON Cronos Group
$2.82 /

+0.01 (+0.36%)

05/11/22 CIBC
CIBC upgrades Cronos to buy on 'multiple reasons for optimism'
05/11/22 Canaccord
Cronos upgraded to Hold on operational improvements at Canaccord
05/11/22 CIBC
Cronos Group upgraded to Outperformer from Neutral at CIBC
05/11/22 Canaccord
Cronos Group upgraded to Hold from Sell at Canaccord
SQ Block
$63.57 /

+2.08 (+3.38%)

06/30/22 Truist
Block price target lowered to $105 from $145 at Truist
06/17/22 Mizuho
Marqeta has negotiating leverage with Square, says Mizuho
06/15/22 Credit Suisse
Block price target lowered to $170 from $180 at Credit Suisse
06/07/22 Mizuho
PayPal sales could rise 20% if Apple enables Venmo tap, says Mizuho
WRBY Warby Parker
$11.19 /

-0.05 (-0.44%)

06/27/22 Loop Capital
Warby Parker price target lowered to $15 from $18 at Loop Capital
05/17/22 Goldman Sachs
Warby Parker downgraded to Neutral from Buy at Goldman Sachs
05/17/22 Baird
Warby Parker price target lowered to $30 from $40 at Baird
05/17/22 Citi
Warby Parker price target lowered to $29 from $41 at Citi
SNAP Snap
$12.89 /

-0.23 (-1.75%)

06/30/22 JMP Securities
Snap price target lowered to $42 from $45 at JMP Securities
06/29/22 JPMorgan
Snap price target lowered to $24 from $26 at JPMorgan
06/22/22 Guggenheim
Snap price target lowered to $18 from $35 at Guggenheim
06/16/22 UBS
Snap price target lowered to $17 from $45 at UBS
NEO NeoGenomics
$8.40 /

+0.25 (+3.07%)

06/02/22 Piper Sandler
NeoGenomics initiated with an Overweight at Piper Sandler
03/29/22 Cowen
NeoGenomics price target lowered to $24 from $42 at Cowen
03/29/22 BTIG
NeoGenomics price target lowered to $28 from $35 at BTIG
03/29/22 SVB Securities
NeoGenomics price target lowered to $20 from $45 at SVB Leerink
MSTR MicroStrategy
$165.00 /

+1.67 (+1.02%)

06/16/22 Jefferies
Jefferies cuts MicroStrategy target, says does not face solvency risk
06/14/22 BTIG
MicroStrategy margin call concerns 'blown out of proportion,' says BTIG
05/23/22 Jefferies
MicroStrategy price target lowered to $215 from $225 at Jefferies
05/16/22 Jefferies
MicroStrategy does not face liquidity, solvency risk, says Jefferies
LSPD Lightspeed
$22.64 /

+0.36 (+1.62%)

06/03/22 Piper Sandler
Lightspeed price target raised to $40 from $39 at Piper Sandler
05/20/22 TD Securities
Lightspeed price target lowered to C$60 from C$80 at TD Securities
05/20/22 Raymond James
Lightspeed price target raised to C$43 from C$40 at Raymond James
05/20/22 Truist
Lightspeed price target lowered to $45 from $60 at Truist
BILI Bilibili
$26.11 /

+0.52 (+2.03%)

06/13/22 JPMorgan
Bilibili price target raised to $25 from $19 at JPMorgan
06/10/22 Citi
Bilibili price target lowered to $45 from $46 at Citi
06/10/22 Barclays
Bilibili price target raised to $26 from $24 at Barclays
06/10/22 ICBC
Bilibili downgraded to Neutral from Outperform at ICBC
GDS GDS Holdings
$34.16 /

+0.86 (+2.58%)

06/06/22 RBC Capital
GDS Holdings price target lowered to $41 from $58 at RBC Capital
05/19/22 Truist
GDS Holdings price target lowered to $75 from $85 at Truist
05/19/22 Cowen
GDS Holdings price target lowered to $47 from $53 at Cowen
05/19/22 Raymond James
GDS Holdings price target lowered to $55 from $68 at Raymond James
NUTX Nutex Health
$3.31 /

+0.09 (+2.80%)

RXRX Recursion Pharmaceuticals
$8.65 /

+0.52 (+6.40%)

04/18/22 BofA
Recursion Pharmaceuticals downgraded to Neutral from Buy at BofA
03/04/22 SVB Securities
Recursion Pharmaceuticals downgraded to Market Perform from Outperform at SVB Leerink
09/21/21 Berenberg
Recursion Pharmaceuticals initiated with a Buy at Berenberg
WRBY Warby Parker
$11.19 /

-0.05 (-0.44%)

SQ Block
$63.57 /

+2.08 (+3.38%)

SNAP Snap
$12.89 /

-0.23 (-1.75%)

SEDG SolarEdge
$276.44 /

+3.57 (+1.31%)

RXRX Recursion Pharmaceuticals
$8.65 /

+0.52 (+6.40%)

RIVN Rivian Automotive
$25.76 /

+0.03 (+0.12%)

NEO NeoGenomics
$8.40 /

+0.25 (+3.07%)

MSTR MicroStrategy
$165.00 /

+1.67 (+1.02%)

LSPD Lightspeed
$22.64 /

+0.36 (+1.62%)

GDS GDS Holdings
$34.16 /

+0.86 (+2.58%)

FTCH Farfetch
$7.36 /

+0.18 (+2.51%)

CRON Cronos Group
$2.82 /

+0.01 (+0.36%)

BILI Bilibili
$26.11 /

+0.52 (+2.03%)

  • 18
    Mar
  • 10
    Nov
  • 29
    Sep
  • 09
    Aug
WRBY Warby Parker
$11.19 /

-0.05 (-0.44%)

SQ Block
$63.57 /

+2.08 (+3.38%)

SNAP Snap
$12.89 /

-0.23 (-1.75%)

SEDG SolarEdge
$276.44 /

+3.57 (+1.31%)

RIVN Rivian Automotive
$25.76 /

+0.03 (+0.12%)

MSTR MicroStrategy
$165.00 /

+1.67 (+1.02%)

GDS GDS Holdings
$34.16 /

+0.86 (+2.58%)

CRON Cronos Group
$2.82 /

+0.01 (+0.36%)

BILI Bilibili
$26.11 /

+0.52 (+2.03%)

WRBY Warby Parker
$11.19 /

-0.05 (-0.44%)

SQ Block
$63.57 /

+2.08 (+3.38%)

SNAP Snap
$12.89 /

-0.23 (-1.75%)

SEDG SolarEdge
$276.44 /

+3.57 (+1.31%)

RIVN Rivian Automotive
$25.76 /

+0.03 (+0.12%)

NEO NeoGenomics
$8.40 /

+0.25 (+3.07%)

MSTR MicroStrategy
$165.00 /

+1.67 (+1.02%)

LSPD Lightspeed
$22.64 /

+0.36 (+1.62%)

GDS GDS Holdings
$34.16 /

+0.86 (+2.58%)

FTCH Farfetch
$7.36 /

+0.18 (+2.51%)

CRON Cronos Group
$2.82 /

+0.01 (+0.36%)

BILI Bilibili
$26.11 /

+0.52 (+2.03%)

WRBY Warby Parker
$11.19 /

-0.05 (-0.44%)

SQ Block
$63.57 /

+2.08 (+3.38%)

SNAP Snap
$12.89 /

-0.23 (-1.75%)

SEDG SolarEdge
$276.44 /

+3.57 (+1.31%)

RIVN Rivian Automotive
$25.76 /

+0.03 (+0.12%)

NEO NeoGenomics
$8.40 /

+0.25 (+3.07%)

MSTR MicroStrategy
$165.00 /

+1.67 (+1.02%)

LSPD Lightspeed
$22.64 /

+0.36 (+1.62%)

GDS GDS Holdings
$34.16 /

+0.86 (+2.58%)

FTCH Farfetch
$7.36 /

+0.18 (+2.51%)

CRON Cronos Group
$2.82 /

+0.01 (+0.36%)

BILI Bilibili
$26.11 /

+0.52 (+2.03%)

Recommendations
Merit Medical price target lowered to $70 from $75 at Piper Sandler » 04:45
07/01/22
07/01
04:45
07/01/22
04:45
MMSI

Merit Medical

$54.14 /

-0.02 (-0.04%)

Piper Sandler analyst…

Piper Sandler analyst Jason Bednar lowered the firm's price target on Merit Medical Systems to $70 from $75 and keeps an Overweight rating on the shares after hosting meetings with management. The analyst says management had "unwavering confidence" in hitting the fiscal 2023 18%-plus operating margin target embedded in its "Foundations For Growth" initiative. This "speaks volumes" in light of Q1 margin pressures and inflation uncertainties, and puts Merit Medical in a "select group" that should post consistent margin expansion over at least the next three years, Bednar tells investors in a research note. He's a buyer of the stock into next month's Q2 results.

ShowHide Related Items >><<
MMSI Merit Medical
$54.14 /

-0.02 (-0.04%)

MMSI Merit Medical
$54.14 /

-0.02 (-0.04%)

04/28/22 Barrington
Merit Medical price target lowered to $78 from $82 at Barrington
03/10/22 Piper Sandler
Piper not ruling out Merit Medical takeout despite 'odd' timing
02/25/22 Barrington
Merit Medical price target raised to $82 from $78 at Barrington
02/25/22 Piper Sandler
Merit Medical price target lowered to $75 from $79 at Piper Sandler
MMSI Merit Medical
$54.14 /

-0.02 (-0.04%)

MMSI Merit Medical
$54.14 /

-0.02 (-0.04%)

Wednesday
Conference/Events
Merit Medical management to meet virtually with Piper Sandler » 04:55
06/29/22
06/29
04:55
06/29/22
04:55
MMSI

Merit Medical

$53.76 /

-1.15 (-2.09%)

Virtual Meetings to be…

Virtual Meetings to be held on June 28-29 hosted by Piper Sandler.

ShowHide Related Items >><<
MMSI Merit Medical
$53.76 /

-1.15 (-2.09%)

MMSI Merit Medical
$53.76 /

-1.15 (-2.09%)

04/28/22 Barrington
Merit Medical price target lowered to $78 from $82 at Barrington
03/10/22 Piper Sandler
Piper not ruling out Merit Medical takeout despite 'odd' timing
02/25/22 Barrington
Merit Medical price target raised to $82 from $78 at Barrington
02/25/22 Piper Sandler
Merit Medical price target lowered to $75 from $79 at Piper Sandler
MMSI Merit Medical
$53.76 /

-1.15 (-2.09%)

MMSI Merit Medical
$53.76 /

-1.15 (-2.09%)

Over a week ago
Hot Stocks
Brainsway announces insurance coverage by Israeli Ministry of Health » 08:16
06/28/22
06/28
08:16
06/28/22
08:16
BWAY

Brainsway

$5.21 /

+0.12 (+2.36%)

BrainsWay announced that,…

BrainsWay announced that, for the first time, the Israeli Ministry of Health has approved coverage applicable to its Deep TM system for the treatment of depression. The inclusion of the treatment within Israel's health basket of essential medical services means that the country's health funds must now make the treatment available to qualifying patients free of charge. Qualifying patients include adults over the age of 21 with depression who have either not responded to two prior antidepressants, or who are intolerant to other treatment alternatives. Coverage may be provided for up to 40 treatment sessions, which are to be administered in hospitals.

ShowHide Related Items >><<
BWAY Brainsway
$5.21 /

+0.12 (+2.36%)

BWAY Brainsway
$5.21 /

+0.12 (+2.36%)

03/02/22 Loop Capital
Loop Capital starts Brainsway at Buy with $15 price target
03/02/22 Loop Capital
Brainsway initiated with a Buy at Loop Capital
02/10/22 Northland
Brainsway transferred with an Outperform at Northland
11/29/21 H.C. Wainwright
Brainsway price target raised to $15 from $14 at H.C. Wainwright
BWAY Brainsway
$5.21 /

+0.12 (+2.36%)

Conference/Events
Merit Medical management to meet virtually with Piper Sandler » 04:55
06/28/22
06/28
04:55
06/28/22
04:55
MMSI

Merit Medical

$54.88 /

+2 (+3.78%)

Virtual Meetings to be…

Virtual Meetings to be held on June 28-29 hosted by Piper Sandler.

ShowHide Related Items >><<
MMSI Merit Medical
$54.88 /

+2 (+3.78%)

MMSI Merit Medical
$54.88 /

+2 (+3.78%)

04/28/22 Barrington
Merit Medical price target lowered to $78 from $82 at Barrington
03/10/22 Piper Sandler
Piper not ruling out Merit Medical takeout despite 'odd' timing
02/25/22 Barrington
Merit Medical price target raised to $82 from $78 at Barrington
02/25/22 Piper Sandler
Merit Medical price target lowered to $75 from $79 at Piper Sandler
MMSI Merit Medical
$54.88 /

+2 (+3.78%)

MMSI Merit Medical
$54.88 /

+2 (+3.78%)

Conference/Events
LeMaitre management to meet with Barrington » 04:55
06/28/22
06/28
04:55
06/28/22
04:55
LMAT

LeMaitre

$45.37 /

+0.32 (+0.71%)

Meeting to be held on…

Meeting to be held on June 28 hosted by Barrington.

ShowHide Related Items >><<
LMAT LeMaitre
$45.37 /

+0.32 (+0.71%)

LMAT LeMaitre
$45.37 /

+0.32 (+0.71%)

04/29/22 Barrington
LeMaitre price target lowered to $50 from $54 at Barrington
02/25/22 Barrington
LeMaitre price target lowered to $54 from $62 at Barrington
09/16/21
Fly Intel: Top five analyst initiations
09/16/21 Jefferies
Jefferies starts LeMaitre at Buy on ArteGraft upside potential
LMAT LeMaitre
$45.37 /

+0.32 (+0.71%)

  • 14
    Jul
On The Fly
Sell these stocks now, proven algorithm says » 13:51
06/24/22
06/24
13:51
06/24/22
13:51
WRBY

Warby Parker

$14.11 /

+0.64 (+4.75%)

, DNA

Ginkgo Bioworks

$2.85 /

-0.085 (-2.90%)

, RXRX

Recursion Pharmaceuticals

$8.49 /

-0.785 (-8.46%)

, MSTR

MicroStrategy

$200.01 /

+11.95 (+6.35%)

, SWTX

SpringsWorks Therapeutics

$25.22 /

-0.38 (-1.48%)

Each week, The Fly will…

ShowHide Related Items >><<
WRBY Warby Parker
$14.11 /

+0.64 (+4.75%)

SWTX SpringsWorks Therapeutics
$25.22 /

-0.38 (-1.48%)

RXRX Recursion Pharmaceuticals
$8.49 /

-0.785 (-8.46%)

MSTR MicroStrategy
$200.01 /

+11.95 (+6.35%)

DNA Ginkgo Bioworks
$2.85 /

-0.085 (-2.90%)

WRBY Warby Parker
$14.11 /

+0.64 (+4.75%)

05/17/22 Goldman Sachs
Warby Parker downgraded to Neutral from Buy at Goldman Sachs
05/17/22 Baird
Warby Parker price target lowered to $30 from $40 at Baird
05/17/22 Citi
Warby Parker price target lowered to $29 from $41 at Citi
03/30/22 Stifel
Warby Parker initiated with a Hold at Stifel
DNA Ginkgo Bioworks
$2.85 /

-0.085 (-2.90%)

06/16/22 Jefferies
Ginkgo Bioworks price target lowered to $4.35 from $11.50 at Jefferies
05/18/22 BofA
BofA downgrades Ginkgo Bioworks to Underperform, halves target to $3
05/18/22 BofA
Ginkgo Bioworks downgraded to Underperform from Neutral at BofA
03/31/22 BTIG
Ginkgo Bioworks price target lowered to $6 from $12 at BTIG
RXRX Recursion Pharmaceuticals
$8.49 /

-0.785 (-8.46%)

04/18/22 BofA
Recursion Pharmaceuticals downgraded to Neutral from Buy at BofA
03/04/22 SVB Securities
Recursion Pharmaceuticals downgraded to Market Perform from Outperform at SVB Leerink
09/21/21 Berenberg
Recursion Pharmaceuticals initiated with a Buy at Berenberg
MSTR MicroStrategy
$200.01 /

+11.95 (+6.35%)

06/16/22 Jefferies
Jefferies cuts MicroStrategy target, says does not face solvency risk
06/14/22 BTIG
MicroStrategy margin call concerns 'blown out of proportion,' says BTIG
05/23/22 Jefferies
MicroStrategy price target lowered to $215 from $225 at Jefferies
05/16/22 Jefferies
MicroStrategy does not face liquidity, solvency risk, says Jefferies
SWTX SpringsWorks Therapeutics
$25.22 /

-0.38 (-1.48%)

06/06/22 H.C. Wainwright
SpringsWorks price target lowered to $95 from $142 at H.C. Wainwright
06/06/22 H.C. Wainwright
Turning Point Therapeutics downgraded to Neutral from Buy at H.C. Wainwright
05/27/22 Wedbush
SpringsWorks Therapeutics price target lowered to $50 from $110 at Wedbush
05/24/22 Goldman Sachs
SpringsWorks Therapeutics price target raised to $82 from $76 at Goldman Sachs
WRBY Warby Parker
$14.11 /

+0.64 (+4.75%)

SWTX SpringsWorks Therapeutics
$25.22 /

-0.38 (-1.48%)

RXRX Recursion Pharmaceuticals
$8.49 /

-0.785 (-8.46%)

MSTR MicroStrategy
$200.01 /

+11.95 (+6.35%)

DNA Ginkgo Bioworks
$2.85 /

-0.085 (-2.90%)

  • 29
    Sep
WRBY Warby Parker
$14.11 /

+0.64 (+4.75%)

MSTR MicroStrategy
$200.01 /

+11.95 (+6.35%)

WRBY Warby Parker
$14.11 /

+0.64 (+4.75%)

SWTX SpringsWorks Therapeutics
$25.22 /

-0.38 (-1.48%)

MSTR MicroStrategy
$200.01 /

+11.95 (+6.35%)

DNA Ginkgo Bioworks
$2.85 /

-0.085 (-2.90%)

WRBY Warby Parker
$14.11 /

+0.64 (+4.75%)

MSTR MicroStrategy
$200.01 /

+11.95 (+6.35%)

DNA Ginkgo Bioworks
$2.85 /

-0.085 (-2.90%)

Recommendations
DexCom price target lowered to $105 from $135 at BTIG » 07:22
06/24/22
06/24
07:22
06/24/22
07:22
DXCM

DexCom

$75.21 /

+3.57 (+4.98%)

BTIG analyst Marie…

BTIG analyst Marie Thibault lowered the firm's price target on DexCom to $105 from post-split $135 but keeps a Buy rating on the shares as part of a broader research note on medical technology and digital health names. The pain across the sector has been indiscriminate, and many companies that still offer healthy fundamentals, strong operating track records, and important product pipelines are losing a large portion of their market value, the analyst tells investors in a research note. Thibault adds that she prefers stocks with large cash balances, a line of sight to cash flow-breakeven, consistent quarterly outperformance, and multiples that compare well against pre-COVID levels.

ShowHide Related Items >><<
DXCM DexCom
$75.21 /

+3.57 (+4.98%)

DXCM DexCom
$75.21 /

+3.57 (+4.98%)

06/01/22 Lake Street
Abbott approval for Libre 3 'a huge positive' for Tandem, says Lake Street
05/31/22 Piper Sandler
Abbott approval bodes well for DexCom, Tandem, says Piper Sandler
05/31/22 Stifel
DexCom M&A response should put an end to recent dislocation, says Stifel
05/31/22 BTIG
DexCom shares may be volatile after 'squashing' M&A report, says BTIG
DXCM DexCom
$75.21 /

+3.57 (+4.98%)

DXCM DexCom
$75.21 /

+3.57 (+4.98%)

DXCM DexCom
$75.21 /

+3.57 (+4.98%)

DXCM DexCom
$75.21 /

+3.57 (+4.98%)

Conference/Events
LeMaitre management to meet with Barrington » 07:22
06/23/22
06/23
07:22
06/23/22
07:22
LMAT

LeMaitre

$43.27 /

+0.36 (+0.84%)

Meeting to be held on…

Meeting to be held on June 28 hosted by Barrington.

ShowHide Related Items >><<
LMAT LeMaitre
$43.27 /

+0.36 (+0.84%)

LMAT LeMaitre
$43.27 /

+0.36 (+0.84%)

04/29/22 Barrington
LeMaitre price target lowered to $50 from $54 at Barrington
02/25/22 Barrington
LeMaitre price target lowered to $54 from $62 at Barrington
09/16/21
Fly Intel: Top five analyst initiations
09/16/21 Jefferies
Jefferies starts LeMaitre at Buy on ArteGraft upside potential
LMAT LeMaitre
$43.27 /

+0.36 (+0.84%)

  • 14
    Jul
Conference/Events
Merit Medical management to meet virtually with Piper Sandler » 16:43
06/21/22
06/21
16:43
06/21/22
16:43
MMSI

Merit Medical

$52.13 /

+0.17 (+0.33%)

Virtual Meetings to be…

Virtual Meetings to be held on June 28-29 hosted by Piper Sandler.

ShowHide Related Items >><<
MMSI Merit Medical
$52.13 /

+0.17 (+0.33%)

MMSI Merit Medical
$52.13 /

+0.17 (+0.33%)

04/28/22 Barrington
Merit Medical price target lowered to $78 from $82 at Barrington
03/10/22 Piper Sandler
Piper not ruling out Merit Medical takeout despite 'odd' timing
02/25/22 Barrington
Merit Medical price target raised to $82 from $78 at Barrington
02/25/22 Piper Sandler
Merit Medical price target lowered to $75 from $79 at Piper Sandler
MMSI Merit Medical
$52.13 /

+0.17 (+0.33%)

MMSI Merit Medical
$52.13 /

+0.17 (+0.33%)

Get Full Fly Access

Breaking market intelligence sent straight to you
Our team of experts analyze every news story and filter out the noise to deliver real-time market moving news.
Up-to-date information on important industry events
Get real-time updates on events that are moving the market—from conferences and calls to syndicate announcements.
News focused on the companies in your portfolio
Create up to 12 portfolios with 150 stocks each, and see how active they are in market news.